Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

7.4K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.4K
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

144
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
144
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

475
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
475
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

63
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
63
Brain Imaging01:14

Brain Imaging

331
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RxLegal: Emergency Use Authorizations.

Hospital pharmacy·2023
Same author

Inclusion of Optimal Guidelines for Pharmacists in UpToDate.

The Annals of pharmacotherapy·2022
Same author

RxLegal: The Evolving Legal Landscape of Telehealth.

Hospital pharmacy·2021
Same author

ASHP Guidelines on Medication-Use Evaluation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021
Same author

The Orphan Drug Act: An Appropriate Approval Pathway for Treatments of Rare Diseases?

Hospital pharmacy·2019
Same author

Administration of Injectable Vitamin K Orally.

Hospital pharmacy·2017
Same journal

Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa: A Multicenter Retrospective Cohort Study.

Hospital pharmacy·2026
Same journal

Stability of Diluted Intravenous Metronidazole in 0.9% Sodium Chloride.

Hospital pharmacy·2026
Same journal

Response to Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Significant Published Articles in 2025 for Pharmacy Nutrition Support Practice.

Hospital pharmacy·2026
Same journal

Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Comparison of Cystatin C-Based and Serum Creatinine-Based Renal Function Estimates Against Timed Urine Collection in Critically Ill Patients.

Hospital pharmacy·2026
See all related articles

Related Experiment Video

Updated: Sep 24, 2025

Monitoring Dendritic Cell Migration using 19F / 1H Magnetic Resonance Imaging
08:12

Monitoring Dendritic Cell Migration using 19F / 1H Magnetic Resonance Imaging

Published on: March 20, 2013

12.0K

Transdermal Patch Administration and Magnetic Resonance Imaging (MRI)-2020.

Janna Afanasjeva1, Michael Gabay1, Thomas Poznanski1

  • 1University of Illinois at Chicago, Chicago, IL, USA.

Hospital Pharmacy
|May 6, 2022
PubMed
Summary
This summary is machine-generated.

This updated safety review examines transdermal patches and magnetic resonance imaging (MRI) risks. New formulations require checking for metallic content before MRI scans to ensure patient safety.

Keywords:
adverse drug reactionsdrug informationmedicaiton safety

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K

Related Experiment Videos

Last Updated: Sep 24, 2025

Monitoring Dendritic Cell Migration using 19F / 1H Magnetic Resonance Imaging
08:12

Monitoring Dendritic Cell Migration using 19F / 1H Magnetic Resonance Imaging

Published on: March 20, 2013

12.0K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K

Area of Science:

  • Medical Safety
  • Radiology
  • Pharmaceuticals

Background:

  • The 2010 article highlighted safety concerns with transdermal patches during MRI.
  • New transdermal medications and formulation changes necessitate an updated safety review.
  • Metallic content in patches poses potential risks during MRI procedures.

Purpose of the Study:

  • To update safety information regarding transdermal patches and MRI.
  • To identify metallic content in FDA-approved transdermal medications through October 2020.
  • To provide guidance on reapplication procedures after MRI scans.

Main Methods:

  • Research of Food and Drug Administration (FDA)-approved transdermal medications up to October 2020.
  • Determination of metallic content in transdermal patch formulations.
  • Review of manufacturer guidelines for MRI use and post-scan reapplication.

Main Results:

  • New transdermal products have emerged since the original 2010 publication.
  • Changes in metallic content have been noted in existing transdermal formulations.
  • Manufacturers have not evaluated the safety of transdermal products during MRI scans.

Conclusions:

  • Healthcare providers must verify the metallic content of transdermal patches before MRI.
  • Consult prescribing information or manufacturers for the most current safety data.
  • The use of transdermal products during MRI has not been evaluated by manufacturers.